Clinical Trial Update: Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency [Phase 4]

View source ↗

Summary

Phase 4 trial evaluates efficacy and safety of Ginkgo Biloba Extract in mild cognitive impairment and cerebrovascular insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Insufficiency
• Cognitive Impairment

Drugs mentioned

• Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: Milsing d.o.o. | Conditions: Mild Cognitive Impairment, Cerebrovascular Insufficiency | Phase 4 | Status: COMPLETED